Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.
 |
Vidyya |
|
Ars Medica Home |
|
Vidyya Archives |
|
Search Vidyya |
|
Ex Libris |
|
Subscriptions |
|
About Vidyya |
|
|
 |
In Today's Vidyya Are We Ready For Our Gene-Based Future? |
|
Donate Your Genetic Material - For A Good Cause? The 01 August 2000 issue of the New York Times contains a front page article on a small, California company, DNA.com. The companiy is a start-up led by no less than the famous James D. Watson, the discoverer of the DNA double helix, and invested in by no other than James H. Clark, founder of Netscape, is asking for over 100,000 volunteers to donate their DNA. More... |
|
Genetic Terms - The Language Of The Future With companies looking for "genetic volunteers" and the possibilities of profit from the reselling of genetic material, everyone is going to need to know a little bit about the genetic world. A good place to start is with the lingo. Vidyya presents this glossary of genetic terms for your information. More... |
|
Recommendations Of The Task Force On Genetic Information And Insurance
As more companies similar to DNA.com sprout up on the world entrepreneurial landscape, the ethics of genetic research will come under intense scrutiny. As early as 1993, the US government developed guidelines to help companies and individuals deal with some of these issues. The following summary is from a US Task Force given the assignment of exploring the relationship between genetic information and the insurance industry. More... |
|
Important Warnings Regarding Life-Threatening
Pancreatitis For Depakote, Depacon, And
Depakene
This FDA communication is to advise health professionals of an update to the warnings section in the labeling for Depakote ® Tablets, Depakote ® Sprinkle Capsules, and Depacon ® regarding pancreatitis associated with valproate use. More... |
|
Health Professionals Alerted To Severe Hypersensitivity Reactions To Ziagen (Abacavir Sulfate) Glaxo Wellcome Inc., is notifying health professionals of a revised warning in the labeling for Ziagen (abacavir sulfate) about fatal hypersensitivity reactions to abacavir in patients presenting with respiratory symptoms. More... |
Ars Medica Home | Ex Libris | Vidyya |
Subscription Information | About Vidyya | Vidyya Archives |
Editor: Susan K. Boyer, RN
© RAmEx Ars Medica, Inc. All rights reserved.